These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 28124594)

  • 1. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
    Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
    Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontier View on Nanotechnological Strategies for Neuro-therapy.
    Azhar A; Ashraf GM; Zia Q; Ansari SA; Perveen A; Hafeez A; Saeed M; Kamal MA; Alexiou A; Ganash M; Yarla NS; Baeesa SS; Alfiky MM; Bajouh OS
    Curr Drug Metab; 2018; 19(7):596-604. PubMed ID: 29512448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.
    Masoudi Asil S; Ahlawat J; Guillama Barroso G; Narayan M
    Biomater Sci; 2020 Aug; 8(15):4109-4128. PubMed ID: 32638706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders.
    Nguyen TT; Nguyen-Thi PT; Nguyen THA; Ho TT; Tran NM; Van Vo T; Van Vo G
    Mol Diagn Ther; 2023 Jul; 27(4):457-473. PubMed ID: 37217723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent prospective of surface engineered Nanoparticles in the management of Neurodegenerative disorders.
    Singh D; Kapahi H; Rashid M; Prakash A; Majeed AB; Mishra N
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):780-91. PubMed ID: 26107112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
    Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
    Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
    Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
    Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerium oxide nanoparticles: a 'radical' approach to neurodegenerative disease treatment.
    Naz S; Beach J; Heckert B; Tummala T; Pashchenko O; Banerjee T; Santra S
    Nanomedicine (Lond); 2017 Mar; 12(5):545-553. PubMed ID: 28181459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growing synergy of nanodiamonds in neurodegenerative interventions.
    Saraf J; Kalia K; Bhattacharya P; Tekade RK
    Drug Discov Today; 2019 Feb; 24(2):584-594. PubMed ID: 30408527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic applications of nanoparticles in neurodegenerative disorders.
    Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
    Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
    Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
    Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases.
    Riccardi C; Napolitano F; Montesarchio D; Sampaolo S; Melone MAB
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
    Spuch C; Saida O; Navarro C
    Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobiomaterials' applications in neurodegenerative diseases.
    Silva Adaya D; Aguirre-Cruz L; Guevara J; Ortiz-Islas E
    J Biomater Appl; 2017 Feb; 31(7):953-984. PubMed ID: 28178902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.